Top Pharmaceuticals companies in Switzerland by Free Cash Flow Yield

This ranking features the top 18 Pharmaceuticals companies in Switzerland ranked by Free Cash Flow Yield, averaging a Free Cash Flow Yield of -12.78%, for June 19, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Pharmaceuticals company in Switzerland has the highest Free Cash Flow Yield ?

The Pharmaceuticals company in Switzerland with the highest Free Cash Flow Yield is AC Immune SA (NasdaqGM: ACIU) at 25.31%.
Which Pharmaceuticals company in Switzerland has the lowest Free Cash Flow Yield ?

The Pharmaceuticals company in Switzerland with the lowest Free Cash Flow Yield is Evolva Holding SA (Swiss Stock Exchange: EVE.SW) at None.

What are the top 10 Pharmaceuticals companies in Switzerland by Free Cash Flow Yield ?

The top 10 Pharmaceuticals companies in Switzerland by Free Cash Flow Yield are AC Immune SA, Basilea Pharmaceutica AG, Roche Holding AG, Novartis AG, Galenica AG, PolyPeptide Group AG, Sandoz Group AG, Siegfried Holding AG, Lonza Group AG and Ypsomed Holding AG.
What are the bottom 10 Pharmaceuticals companies in Switzerland by Free Cash Flow Yield ?

The bottom 10 Pharmaceuticals companies in Switzerland by Free Cash Flow Yield are Evolva Holding SA, Addex Therapeutics Ltd, NLS Pharmaceutics AG, Idorsia Ltd, Molecular Partners AG, Santhera Pharmaceuticals Holding AG, Oculis Holding AG, Bachem Holding AG, Ypsomed Holding AG and Lonza Group AG.